Dor Lavie

757 total citations · 1 hit paper
2 papers, 481 citations indexed

About

Dor Lavie is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Dor Lavie has authored 2 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 1 paper in Molecular Biology and 1 paper in Immunology. Recurrent topics in Dor Lavie's work include Cancer Cells and Metastasis (2 papers), IL-33, ST2, and ILC Pathways (1 paper) and Cancer Genomics and Diagnostics (1 paper). Dor Lavie is often cited by papers focused on Cancer Cells and Metastasis (2 papers), IL-33, ST2, and ILC Pathways (1 paper) and Cancer Genomics and Diagnostics (1 paper). Dor Lavie collaborates with scholars based in Israel. Dor Lavie's co-authors include Neta Erez, Aviad Ben‐Shmuel, Ruth Scherz‐Shouval, Lea Monteran, Ophir Shani, Galia Tsarfaty, Tatiana Vorobyov, Camila Avivi, Noam Cohen and Yael Raz and has published in prestigious journals such as Cancer Research and Nature Cancer.

In The Last Decade

Dor Lavie

2 papers receiving 479 citations

Hit Papers

Cancer-associated fibroblasts in the single-cell era 2022 2026 2023 2024 2022 100 200 300

Peers

Dor Lavie
Comparison fields: 5 of 53
  • Oncology 273
  • Molecular Biology 204
  • Immunology 192
  • Cancer Research 118
  • Pulmonary and Respiratory Medicine 77
Replace Kellie A. Mouchemore with:
Kellie A. Mouchemore Australia
Barbora Peltanová Czechia
Priska Auf der Maur Switzerland
Mohammad Awaji Saudi Arabia
Koki Maeda Japan
Susanne Schaten Germany
Adilson Fonseca Teixeira Australia
Taisaku Kuwahata Japan
Christian Eisen Germany
Jia-Bin Lu China
Kellie A. Mouchemore Australia View profile →
Citations per field, relative to Dor Lavie
Dor Lavie · 1×
Citations per year, relative to Dor Lavie
Dor Lavie · 1×

Countries citing papers authored by Dor Lavie

Since Specialization
Citations

This map shows the geographic impact of Dor Lavie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dor Lavie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dor Lavie more than expected).

Fields of papers citing papers by Dor Lavie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dor Lavie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dor Lavie. The network helps show where Dor Lavie may publish in the future.

Co-authorship network of co-authors of Dor Lavie

This figure shows the co-authorship network connecting the top 25 collaborators of Dor Lavie. A scholar is included among the top collaborators of Dor Lavie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dor Lavie. Dor Lavie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
# Work Indexed citations
1
Cancer-associated fibroblasts in the single-cell era breakdown →
371
2 110

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026